1-tert-Butyl-3-{6-(3,5-dimethoxy-phenyl)-2-[3-(4-methyl-piperazin-1-yl)-propylamino]-pyrido[2,3-d]pyrimidin-7-yl}-urea

ID: ALA189059

PubChem CID: 5330167

Max Phase: Preclinical

Molecular Formula: C28H40N8O3

Molecular Weight: 536.68

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(C)CC4)nc3nc2NC(=O)NC(C)(C)C)c1

Standard InChI:  InChI=1S/C28H40N8O3/c1-28(2,3)34-27(37)33-25-23(19-14-21(38-5)17-22(15-19)39-6)16-20-18-30-26(32-24(20)31-25)29-8-7-9-36-12-10-35(4)11-13-36/h14-18H,7-13H2,1-6H3,(H3,29,30,31,32,33,34,37)

Standard InChI Key:  VYWXBPWMVHMUQW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 42  0  0  0  0  0  0  0  0999 V2000
    0.2292   -2.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4833   -2.5042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9083   -2.5042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1958   -2.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9542   -2.5125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9542   -3.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1958   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9500   -0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6250   -2.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4833   -0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6250   -1.2667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6667   -3.7542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9208   -4.9917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4833   -5.8167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9083   -0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9500   -0.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6625   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2375   -3.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3792   -0.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6625    0.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3792   -0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3792   -3.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3458   -2.5125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2083   -6.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4833   -4.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9208   -5.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -4.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6625    1.2125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1000   -1.2750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6333   -4.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6333   -3.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292   -6.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3458   -3.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0917   -2.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7917   -4.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9667   -2.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3750    1.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0917   -2.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  4  2  0
  4  2  1  0
  5  1  1  0
  6  1  1  0
  7  5  1  0
  8 11  1  0
  9  6  1  0
 10  3  1  0
 11  6  2  0
 12 16  1  0
 13  7  1  0
 14 31  1  0
 15 26  1  0
 16  8  2  0
 17  9  1  0
 18  9  2  0
 19  7  2  0
 20 22  2  0
 21 17  2  0
 22 18  1  0
 23 13  1  0
 24 10  1  0
 25 27  1  0
 26 28  1  0
 27 14  1  0
 28 14  1  0
 29 21  1  0
 30 22  1  0
 31 32  1  0
 32 34  1  0
 33 15  1  0
 34 24  1  0
 35 23  1  0
 36 23  1  0
 37 23  1  0
 38 29  1  0
 39 30  1  0
  8  4  1  0
 20 21  1  0
 12 10  2  0
 25 15  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor (287 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pdgfrb Platelet-derived growth factor receptor beta (494 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tyrosine-protein kinase SRC (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pdgfra Platelet-derived growth factor receptor (PDGFr) (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 536.68Molecular Weight (Monoisotopic): 536.3223AlogP: 3.68#Rotatable Bonds: 9
Polar Surface Area: 116.77Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.52CX Basic pKa: 8.04CX LogP: 2.72CX LogD: 1.99
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.35Np Likeness Score: -1.06

References

1. Thompson AM, Delaney AM, Hamby JM, Schroeder MC, Spoon TA, Crean SM, Showalter HD, Denny WA..  (2005)  Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases.,  48  (14): [PMID:16000000] [10.1021/jm0500931]

Source